Dr. Reddy's Laboratories Ltd. NSE: DRREDDY | BSE: 500124

Turnaround Potential

Download real time

1308.40 7.00 (0.54%)

28.27% Gain from 52W Low

1.4M

NSE+BSE Volume

NSE 23 Sep, 2025 3:31 PM (IST)

Dr. Reddy's Laboratories Ltd. share price target

Dr. Reddy's Laboratories Ltd. has an average share price target of 1278.56. The consensus estimate represents a downside of -2.28% from the last price of 1308.40. View 18 reports from 9 analysts offering long-term price targets for Dr. Reddy's Laboratories Ltd..

Reco - This broker has downgraded this stock from it's previous report.
(eg. - Buy->Hold)

Target - Broker has maintained previous recommendation but reduced share price target.

Reco - This broker has upgraded this stock from it's previous report.
(eg. - Sell->Hold)

Target - Broker has maintained previous recommendation but increased share price target.

Click on any table column to sort reports by date, stock name, broker, price, target, upside or recommendation.

Summary	Date	Stock	Author	LTP	Target	Price at reco (Change since reco%)	Upside(%)	Type	Report		Discuss
	24 Sep 2025	Dr. Reddy's Labs	Consensus Share Price Target	1308.40	1285.13	-	-1.78	hold	pdf Detailed Estimates
	06 Nov 2024	Dr. Reddy's Labs	Emkay	1308.40	1070.00	1302.10 (0.48%)	Target met	Sell	pdf post cache		Broker Report Operationally in line; gross margin weakness a clear negative Emkay Adjusted for multiple one-offs, Dr Reddy’s’ 2QFY25 PAT was in line with our and street estimates. EBITDA was marginally ahead, aided by a sales beat in Russia and other emerging markets, and lower SG&A. pdf Copy Link Share on Share on Share on Share on Alert
	06 Nov 2024	Dr. Reddy's Labs	BOB Capital Markets Ltd.	1308.40	1427.00	1302.10 (0.48%)	9.06	Hold	pdf post cache		Broker Report Dr Reddy's Labs (HOLD): Healthy Q2; margins post gRevlimid LOE to remain wary BOB Capital Markets Ltd. Revenue/EBITDA earnings above our and street estimates. APAT ~46% above estimates. Estimates adjusted for JV and impairment cost pdf Copy Link Share on Share on Share on Share on Alert
	06 Nov 2024	Dr. Reddy's Labs	ICICI Securities Limited	1308.40	1270.00	1302.10 (0.48%)	Target met	Hold	pdf post cache		Broker Report Decent print; work on growth levers underway ICICI Securities Limited Dr. Reddy’s Laboratories’ (DRL) Q2FY25 performance, adjusted for acquisition-related expenses (INR 561mn) and impairment charge of gNuvaring (INR 924mn), was ahead of our expectations pdf Copy Link Share on Share on Share on Share on Alert
	06 Nov 2024	Dr. Reddy's Labs	Axis Direct	1308.40	1535.00	1302.10 (0.48%)	17.32	Buy	pdf post cache		Broker Report Result Update:Dr Reddys Labs Axis Direct we upgrade our recommendation on DR. RD to BUY from HOLD, with a target price of Rs 1,535/share and an upside potential of 20% from the CMP. pdf Copy Link Share on Share on Share on Share on Alert
	06 Nov 2024	Dr. Reddy's Labs	Prabhudas Lilladhar	1308.40	1335.00	1302.10 (0.48%)	Target met	Sell	pdf post cache		Broker Report DR REDDY'S LABS Prabhudas Lilladhar pdf Copy Link Share on Share on Share on Share on Alert
	06 Nov 2024	Dr. Reddy's Labs	ICICI Direct	1308.40	1570.00	1302.10 (0.48%)	19.99	Buy	pdf post cache		Broker Report Dr Reddy's Laboratories ICICI Direct pdf Copy Link Share on Share on Share on Share on Alert
	05 Nov 2024	Dr. Reddy's Labs	Motilal Oswal	1308.40	1390.00	1272.20 (2.85%)	Target met	Neutral	pdf post cache		Broker Report North America/Russia/ROW drive earnings Motilal Oswal Dr Reddy’s Lab (DRRD) delivered in-line 2QFY25 performance. DRRD exhibited robust YoY growth in North America (NA), Russia, and ROW markets and a healthy scale-up in the pharmaceutical services and active ingredients segment. pdf Copy Link Share on Share on Share on Share on Alert
	07 Aug 2024	Dr. Reddy's Labs	Geojit BNP Paribas Target	1308.40	7474.00	6926.35 (-81.11%)	Pre-Bonus/ Split	Hold	pdf post cache		Broker Report DR. REDDY'S LABORATARIES Geojit BNP Paribas pdf Copy Link Share on Share on Share on Share on Alert
	30 Jul 2024	Dr. Reddy's Labs	Axis Direct Target	1308.40	7100.00	6804.15 (-80.77%)	Target met	Hold	pdf post cache		Broker Report Result Update:Dr Reddys Labs Axis Direct We have HOLD rating on the stock pdf Copy Link Share on Share on Share on Share on Alert
	29 Jul 2024	Dr. Reddy's Labs	Prabhudas Lilladhar Target	1308.40	6000.00	6840.05 (-80.87%)	Pre-Bonus/ Split	Sell	pdf post cache		Broker Report DR REDDY'S LABS Prabhudas Lilladhar pdf Copy Link Share on Share on Share on Share on Alert
	29 Jul 2024	Dr. Reddy's Labs	ICICI Direct Reco Target	1308.40	7220.00	6840.05 (-80.87%)	Pre-Bonus/ Split	Hold	pdf post cache		Broker Report Dr Reddy's Laboratories ICICI Direct pdf Copy Link Share on Share on Share on Share on Alert
	28 Jul 2024	Dr. Reddy's Labs	ICICI Securities Limited Reco Target	1308.40	6350.00	6878.65 (-80.98%)	Pre-Bonus/ Split	Sell	pdf post cache		Broker Report Surging dependency on gRevlimid ICICI Securities Limited Higher gRevlimid sales, in our view, formed the premise for Dr. Reddy’s Laboratories’ (DRL) Q1FY25 beat. US sales soared 20.3% YoY to USD 462mn riding on market share gains in existing products. pdf Copy Link Share on Share on Share on Share on Alert
	22 May 2024	Dr. Reddy's Labs	Geojit BNP Paribas Target	1308.40	6338.00	5872.75 (-77.72%)	Target met	Hold	pdf post cache		Broker Report DR. REDDY'S LABORATARIES Geojit BNP Paribas pdf Copy Link Share on Share on Share on Share on Alert
	09 May 2024	Dr. Reddy's Labs	BOB Capital Markets Ltd.	1308.40	5900.00	5877.35 (-77.74%)	Target met	Hold	pdf post cache		Broker Report Dr Reddy's Labs (HOLD): Driven by North America; India continues to underperform BOB Capital Markets Ltd. DRRD reported largely in-line revenue/EBITDA, but higher tax aided in PAT beat pdf Copy Link Share on Share on Share on Share on Alert
	08 May 2024	Dr. Reddy's Labs	Prabhudas Lilladhar Target	1308.40	5700.00	6056.35 (-78.40%)	Target met	Sell	pdf post cache		Broker Report DR REDDY'S LABS Prabhudas Lilladhar pdf Copy Link Share on Share on Share on Share on Alert
	08 May 2024	Dr. Reddy's Labs	SMC online	1308.40		6257.60 (-79.09%)	Pre-Bonus/ Split	Results Update	pdf post cache		Broker Report Dr. Reddy Laboratories SMC online pdf Copy Link Share on Share on Share on Share on Alert
	08 May 2024	Dr. Reddy's Labs	Axis Direct	1308.40	6000.00	6056.35 (-78.40%)	Target met	Hold	pdf post cache		Broker Report Result Update:Dr Reddys Labs Axis Direct We have HOLD on the stock. pdf Copy Link Share on Share on Share on Share on Alert
	07 May 2024	Dr. Reddy's Labs	Motilal Oswal Target	1308.40	6070.00	6257.60 (-79.09%)	Target met	Neutral	pdf post cache		Broker Report US/India drive earnings growth Motilal Oswal Dr. Reddy’s Lab (DRRD) delivered 4QFY24 revenue in line with our estimate. However, EBITDA was lower than expected due to higher SGA expenses and R&D spending. In addition to US generics/branded generics segments, DRRD is enhancing its offering through JVs/partnerships/acquisitions in nutraceuticals, vaccine, women’s health and dietary supplement space. pdf Copy Link Share on Share on Share on Share on Alert
	01 Apr 2024	Dr. Reddy's Labs	Sharekhan Target	1308.40	6537.00	6237.55 (-79.02%)	Target met	Buy	pdf post cache		Broker Report Dr Reddys Labs Sharekhan pdf Copy Link Share on Share on Share on Share on Alert
	01 Feb 2024	Dr. Reddy's Labs	BOB Capital Markets Ltd.	1308.40	5900.00	5993.15 (-78.17%)	Target met	Hold	pdf post cache		Broker Report First Light \| Maruti Suzuki, Dr Reddy's Labs, Voltas, Dixon Technologies, Kajaria Ceramics, Blue Star, KEC … BOB Capital Markets Ltd. MSIL: Healthy all-round performance raise to BUY. DRRD: Buoyant US sales drive performance. VOLT: UCP improving, Qatar business a dampener. DIXON: Mobile business dials up growth; maintain BUY. KJC: Soft demand, intense competition mar quarter. BLSTR: Purple patch continues; maintain BUY. KECI: Pipeline robust, margin improvement delayed. ABSLAMC: Double-digit growth but market share bleed continues. Metals & Mining: Jindal Stainless: Management meet takeaways pdf Copy Link Share on Share on Share on Share on Alert
more loading

* Please note that subscribers can download a maximum of 300 reports a month and 70 reports everyday.

Advisor Screeners